FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes First and only oral antidiabetic fixed-dose combination medication ...
Actos (pioglitazone) is a prescription drug that’s used to treat type 2 diabetes. The drug comes as an oral tablet that’s taken once per day. Actos is used to help manage blood sugar levels in adults ...
Orlando, FL, June 5, 2004 -- Long-term studies using the oral antidiabetic drug ACTOS® (pioglitazone HCl) alone, and in combination with other oral antidiabetic medications, found that it provided ...
Mylan announced that it has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Pioglitazone Tablets, the generic version of Takeda’s Actos tablets. Previously, ...
Please provide your email address to receive an email when new articles are posted on . ORLANDO, Fla. — A combination of an anti-androgen with pioglitazone and metformin in adolescent girls with ...
Actos (pioglitazone) is a prescription drug that’s used to help manage blood sugar levels in people with type 2 diabetes. Actos can cause side effects that range from mild to serious. Examples include ...
Combination therapy w/ ACTOS (pioglitazone HCI) shown to improve components of diabetic dyslipidemia
BOSTON, April 30, 2004 – Results of three studies show the oral anti-diabetic agent ACTOS (R) (pioglitazone HCl), in combination with a sulfonylurea, metformin or insulin, resulted in triglyceride ...
May 21, 2009 — The US Food and Drug Administration (FDA) has approved pioglitazone HCl and metformin HCl extended-release tablets for the adjunctive treatment of type 2 diabetes mellitus, amlodipine ...
Metformin and pioglitazone showed anti-inflammatory effects in patients with multiple sclerosis and metabolic syndrome, according to a new study published in JAMA Neurology. Metformin and pioglitazone ...
Please provide your email address to receive an email when new articles are posted on . Patients with metformin-uncontrolled type 2 diabetes taking insulin and pioglitazone had greater risk for ...
FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes First and only oral antidiabetic fixed-dose combination medication ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results